Fairmount Funds Management LLC Astria Therapeutics, Inc. Transaction History
Fairmount Funds Management LLC
- $628 Million
- Q1 2024
A detailed history of Fairmount Funds Management LLC transactions in Astria Therapeutics, Inc. stock. As of the latest transaction made, Fairmount Funds Management LLC holds 3,554,129 shares of ATXS stock, worth $33.7 Million. This represents 7.97% of its overall portfolio holdings.
Number of Shares
3,554,129
Previous 3,554,129
-0.0%
Holding current value
$33.7 Million
Previous $27.3 Million
83.21%
% of portfolio
7.97%
Previous 3.74%
Shares
3 transactions
Others Institutions Holding ATXS
# of Institutions
122Shares Held
48.8MCall Options Held
3.59MPut Options Held
483K-
Perceptive Advisors LLC New York, NY6.49MShares$61.4 Million1.91% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.28MShares$50 Million7.82% of portfolio
-
Vr Adviser, LLC New York, NY3.61MShares$34.2 Million4.36% of portfolio
-
Black Rock Inc. New York, NY3.59MShares$34 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$24 Million0.0% of portfolio
About Astria Therapeutics, Inc.
- Ticker ATXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,178,000
- Market Cap $144M
- Description
- Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...